History
  • No items yet
midpage
ALTANA PHARMA AG v. TEVA PHARMACEUTICALS USA INC
2:04-cv-02355
| D.N.J. | Nov 5, 2012
Read the full case

Background

  • This is a patent infringement case over U.S. Patent No. 4,758,579 covering pantoprazole and pantoprazole sodium, the active ingredient in Protonix.
  • Nycomed owns the patent; Wyeth markets Protonix in the U.S. under an exclusive license from Nycomed.
  • Defendants Teva, Sun, and KUDCo filed ANDAs; Wyeth began selling infringing pantoprazole products after trial and before judgment in this litigation.
  • A jury trial addressed validity defenses; the court later held KUDCo’s claims of invalidity unfounded; the patent expired July 19, 2010.
  • Nycomed seeks damages for lost profits and/or reasonable royalties under 35 U.S.C. § 284; Nycomed argues profits flowed from Wyeth’s sales, which Nycomed royalties cover.
  • Defendants move for partial summary judgment to preclude Nycomed from recovering lost profits, arguing Nycomed sold no competing finished drug product and profits were generated only through Wyeth’s sales.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether Nycomed may recover lost profits damages Nycomed profits depend on Wyeth sales; substantial competition by Wyeth in the same market. Nycomed did not sell a finished drug; no direct competition with infringing product; lost profits barred. Nycomed cannot recover lost profits; damages limited to reasonable royalty.
Whether the license arrangement defeats lost profits despite royalties Royalties from Wyeth (25%) reflect Nycomed’s profits; lost profits flow from Wyeth’s sales. Even with royalties, Nycomed has not shown direct, culpable loss of profits from its own sales; threshold requirement unmet. Threshold for lost profits not met; damages to Nycomed must be royalties under § 284.

Key Cases Cited

  • Rite-Hite Corp. v. Kelley Co., Inc., 56 F.3d 1538 (Fed. Cir. 1995) (damages must be adequate; not limited to a fixed scope)
  • Gen. Motors Corp. v. Devex Corp., 461 U.S. 648 (U.S. 1983) (but-for damages aim to compensate full injury from infringement)
  • Panduit Corp. v. Stahlin Bros. Fibre Works, 575 F.2d 1152 (6th Cir. 1978) (four-factor test for but-for causation in lost profits)
  • Kearns v. Chrysler Corp., 32 F.3d 1541 (Fed. Cir. 1994) ( Panduit as one method to show but-for causation)
  • Mars, Inc. v. Coin Acceptors, Inc., 527 F.3d 1359 (Fed. Cir. 2008) (lost profits require patentee to show sale of item whose profits were lost)
  • Poly-America, L.P. v. GSE Lining Tech., 383 F.3d 1303 (Fed. Cir. 2004) (royalties to related entity can prevent artificial loss of profits)
Read the full case

Case Details

Case Name: ALTANA PHARMA AG v. TEVA PHARMACEUTICALS USA INC
Court Name: District Court, D. New Jersey
Date Published: Nov 5, 2012
Docket Number: 2:04-cv-02355
Court Abbreviation: D.N.J.